![Brian Deneau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Brian Deneau
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Watchmaker Genomics, Inc.
![]() Watchmaker Genomics, Inc. BiotechnologyHealth Technology Watchmaker Genomics, Inc. applies advanced enzymology to enable breakthrough applications for the reading, writing, and editing of DNA and RNA. Based in Boulder, CO, the Watchmaker team brings decades of collective experience building successful life science companies, commercializing novel technologies, and advancing clinical genomics applications. The company's product portfolio includes enzymes and kits for next-generation sequencing library preparation, synthetic biology, and molecular diagnostics. Watchmaker partners directly with innovative life science companies, commercial sequencing providers, and pioneering research labs. The CEO of the company is John F. Foskett. | Direktor/Vorstandsmitglied | - | - |
Geschäftsführer | 01.08.2019 | - | |
Finanzdirektor/CFO | 01.08.2019 | - |
Karriereverlauf von Brian Deneau
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Director of Finance/CFO | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Watchmaker Genomics, Inc.
![]() Watchmaker Genomics, Inc. BiotechnologyHealth Technology Watchmaker Genomics, Inc. applies advanced enzymology to enable breakthrough applications for the reading, writing, and editing of DNA and RNA. Based in Boulder, CO, the Watchmaker team brings decades of collective experience building successful life science companies, commercializing novel technologies, and advancing clinical genomics applications. The company's product portfolio includes enzymes and kits for next-generation sequencing library preparation, synthetic biology, and molecular diagnostics. Watchmaker partners directly with innovative life science companies, commercial sequencing providers, and pioneering research labs. The CEO of the company is John F. Foskett. | Health Technology |
- Börse
- Insiders
- Brian Deneau
- Erfahrung